Home / Indicator library / Biotechnology and Medical Care / Handa Pharma (6620) overview
Handa Pharma (6620) stock overview
Valuation, financials, growth, ownership, events, dividends, models and adjusted prices for Handa Pharma, on one pageHanda Pharma (6620) snapshot, key figures
Handa Pharma (6620): where today sits in the past year
Current value against the 2025-07-31 to 2026-07-31 range, built from 145 frozen daily vintages.
Seven-dimension checkup for this ticker →
Valuation river
→Financial quality
→Revenue growth
→Ownership structure
→Events, last 90 days
→Yield river
→Valuation models
→Adjusted-price candles
→6620: common questions
What is 6620's P/E ratio?
6620 traded at a price-to-earnings ratio of 18.37x in the official-source snapshot dated 2026-08-03. That figure is frozen as a point-in-time vintage, so a backtest reading it sees only what was knowable that day.
What is 6620's dividend yield?
6620's cash dividend yield was 2.46% on 2026-08-03. Historical dividend policy and gap-fill records are available on the same page.
How fast is 6620's revenue growing?
6620 reported -21.8% year-on-year monthly revenue growth for 2026-06, from the official monthly revenue filing.
Is 6620's price / earnings high or low right now?
6620's price / earnings is 18.37x, which is above its one-year median of 18.09x and sits at the 53rd percentile of the 13.92–23.75x range observed over the last 145 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Is 6620's dividend yield high or low right now?
6620's dividend yield is 2.46%, which is above its one-year median of 2.40% and sits at the 54th percentile of the 1.64–2.96% range observed over the last 145 snapshot dates. Each of those dates is a frozen point-in-time vintage, so the range contains no restated or back-filled values.
Other Biotechnology and Medical Care tickers
160 Taiwan-listed tickers sit in this sector. See the full Biotechnology and Medical Care table.